Literature DB >> 29207385

Real or Perceived: Hyperkalemia Is a Major Deterrent for Renin-Angiotensin Aldosterone System Inhibition in Heart Failure.

Peter A McCullough1,2,3, Janani Rangaswami4,5.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29207385     DOI: 10.1159/000485645

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  4 in total

1.  Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study.

Authors:  Bruce S Spinowitz; Steven Fishbane; Pablo E Pergola; Simon D Roger; Edgar V Lerma; Javed Butler; Stephan von Haehling; Scott H Adler; June Zhao; Bhupinder Singh; Philip T Lavin; Peter A McCullough; Mikhail Kosiborod; David K Packham
Journal:  Clin J Am Soc Nephrol       Date:  2019-05-20       Impact factor: 8.237

2.  Inpatient hospitalisation and mortality rate trends from 2004 to 2014 in the USA: a propensity score-matched case-control study of hyperkalaemia.

Authors:  Kristen Michelle Tecson; Rebecca A Baker; Laura Clariday; Peter A McCullough
Journal:  BMJ Open       Date:  2022-05-19       Impact factor: 3.006

3.  RAAS Inhibitor Prescription and Hyperkalemia Event in Patients With Chronic Kidney Disease: A Single-Center Retrospective Study.

Authors:  Eleonora Riccio; Ivana Capuano; Pasquale Buonanno; Michele Andreucci; Michele Provenzano; Maria Amicone; Manuela Rizzo; Antonio Pisani
Journal:  Front Cardiovasc Med       Date:  2022-02-11

4.  Prevalence, clinical impact and costs of hyperkalaemia: Special focus on heart failure.

Authors:  Aldo P Maggioni; Letizia Dondi; Felicita Andreotti; Silvia Calabria; Massimo Iacoviello; Marco Gorini; Lucio Gonzini; Carlo Piccinni; Giulia Ronconi; Nello Martini
Journal:  Eur J Clin Invest       Date:  2021-03-31       Impact factor: 4.686

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.